SUN PHARMA ADVANCED RESEARCH Q3 FY25 Results

SUN PHARMA ADVANCED RESEARCH has released its financial results for the Q3 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:

Revenue Analysis

• Current Quarter Revenue: Rs. 14.91 Cr
• Quarter-on-Quarter (QoQ) Change: 15.94% (Previous Quarter: Rs. 12.86 Cr )
• Year-on-Year (YoY) Change: 7.58% (Same Quarter Last Year: Rs. 13.86 Cr )

Profitability Metrics

• Net Profit: Rs. -79.51 Cr
• QoQ Profit Change: -25.92% (Previous Quarter: Rs. -107.33 Cr )
• YoY Profit Change: -20.21% (Same Quarter Last Year: Rs. -99.65 Cr )

Shareholder Returns

• Earnings Per Share (EPS): Rs. -2.45
• QoQ EPS Change: -25.98% (Previous Quarter: Rs. -3.31)
• YoY EPS Change: -20.20% (Same Quarter Last Year: Rs. -3.07)

Performance Summary

Mixed

SUN PHARMA ADVANCED RESEARCH showed mixed performance. Sales are up, but profits are down. They might be facing higher costs or tough competition.

This analysis provides a snapshot of SUN PHARMA ADVANCED RESEARCH's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.